Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elastin | 11 | 2012 | 298 | 1.440 |
Why?
|
| Fibroblasts | 16 | 2010 | 4137 | 1.160 |
Why?
|
| Pancreatic Elastase | 7 | 2005 | 126 | 0.840 |
Why?
|
| Lung | 18 | 2007 | 9979 | 0.740 |
Why?
|
| Transforming Growth Factor beta | 8 | 2007 | 1964 | 0.690 |
Why?
|
| Collagen Type I | 6 | 2012 | 616 | 0.580 |
Why?
|
| Interleukin-1 | 3 | 2006 | 1250 | 0.520 |
Why?
|
| Transcription, Genetic | 8 | 2010 | 7574 | 0.280 |
Why?
|
| NF-kappa B | 4 | 2012 | 2475 | 0.280 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2005 | 102 | 0.270 |
Why?
|
| Pulmonary Alveoli | 3 | 2005 | 651 | 0.260 |
Why?
|
| Down-Regulation | 4 | 2007 | 2915 | 0.260 |
Why?
|
| Phenylbutyrates | 2 | 2010 | 72 | 0.240 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 315 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2006 | 829 | 0.240 |
Why?
|
| Emphysema | 2 | 2005 | 238 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2012 | 2864 | 0.210 |
Why?
|
| Immediate-Early Proteins | 2 | 2004 | 444 | 0.210 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2002 | 56 | 0.200 |
Why?
|
| Cells, Cultured | 12 | 2012 | 18926 | 0.190 |
Why?
|
| Gene Expression Regulation | 6 | 2006 | 11856 | 0.190 |
Why?
|
| Interleukin-4 | 2 | 2002 | 1154 | 0.190 |
Why?
|
| RNA, Messenger | 11 | 2010 | 12743 | 0.190 |
Why?
|
| Molecular Biology | 1 | 2005 | 573 | 0.180 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2002 | 262 | 0.180 |
Why?
|
| Amino Acids | 1 | 2006 | 1703 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 585 | 0.160 |
Why?
|
| Actins | 2 | 2005 | 2046 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 1318 | 0.160 |
Why?
|
| Pulmonary Fibrosis | 3 | 2012 | 505 | 0.150 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 927 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1650 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 1585 | 0.140 |
Why?
|
| Vascular Resistance | 1 | 2020 | 932 | 0.140 |
Why?
|
| Rats | 13 | 2012 | 23713 | 0.140 |
Why?
|
| Chromones | 2 | 2007 | 148 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2012 | 8164 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2012 | 698 | 0.120 |
Why?
|
| Morpholines | 2 | 2007 | 581 | 0.110 |
Why?
|
| Dactinomycin | 2 | 2005 | 304 | 0.110 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2004 | 91 | 0.100 |
Why?
|
| Research Report | 1 | 2016 | 367 | 0.100 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2012 | 46 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5775 | 0.100 |
Why?
|
| Bleomycin | 2 | 2002 | 494 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2012 | 5033 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2012 | 153 | 0.090 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 928 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2012 | 223 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2007 | 773 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 2455 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 3700 | 0.090 |
Why?
|
| Lung Injury | 2 | 2005 | 422 | 0.080 |
Why?
|
| Fibronectins | 2 | 2004 | 724 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2006 | 2666 | 0.080 |
Why?
|
| Transgenes | 1 | 2012 | 1008 | 0.080 |
Why?
|
| Animals | 20 | 2012 | 168083 | 0.080 |
Why?
|
| Heart Failure, Systolic | 1 | 2009 | 135 | 0.080 |
Why?
|
| Angiotensin II | 2 | 2012 | 848 | 0.070 |
Why?
|
| Amino Acid Transport System A | 1 | 2006 | 5 | 0.070 |
Why?
|
| RNA | 3 | 2006 | 2708 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2009 | 590 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 129 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2006 | 166 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2006 | 156 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2007 | 8303 | 0.060 |
Why?
|
| Swine | 2 | 2005 | 5909 | 0.060 |
Why?
|
| Leupeptins | 1 | 2005 | 112 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2005 | 188 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1544 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 471 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 475 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4565 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 438 | 0.060 |
Why?
|
| Osteopontin | 1 | 2006 | 302 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2007 | 479 | 0.060 |
Why?
|
| Mice | 11 | 2012 | 81324 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 1301 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 656 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 681 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 812 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 2005 | 607 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 588 | 0.050 |
Why?
|
| Veterans | 1 | 2016 | 2652 | 0.050 |
Why?
|
| Biological Transport | 1 | 2006 | 2082 | 0.050 |
Why?
|
| RNA Stability | 1 | 2004 | 317 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2002 | 140 | 0.050 |
Why?
|
| Apoptosis | 2 | 2012 | 9478 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1989 | 0.050 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 254 | 0.050 |
Why?
|
| Acetylation | 1 | 2004 | 1050 | 0.050 |
Why?
|
| Diaphragm | 1 | 2002 | 351 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 613 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10755 | 0.040 |
Why?
|
| Cell Line | 2 | 2005 | 15542 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2005 | 839 | 0.040 |
Why?
|
| Rats, Inbred SHR | 2 | 2010 | 186 | 0.040 |
Why?
|
| Tretinoin | 1 | 2003 | 517 | 0.040 |
Why?
|
| Hypertension | 2 | 2010 | 8537 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2004 | 1463 | 0.040 |
Why?
|
| Base Sequence | 2 | 2012 | 12404 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2061 | 0.040 |
Why?
|
| Insulin | 2 | 2006 | 6588 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 9518 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3776 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2005 | 1488 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2002 | 646 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1696 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2002 | 1200 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2012 | 23415 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2002 | 1516 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2012 | 10421 | 0.030 |
Why?
|
| Phenotype | 2 | 2005 | 16572 | 0.030 |
Why?
|
| Hospitalization | 1 | 2016 | 10712 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2881 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3409 | 0.030 |
Why?
|
| Quinazolines | 1 | 2002 | 1371 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2012 | 22129 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1865 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 4340 | 0.030 |
Why?
|
| Reference Values | 1 | 2002 | 4922 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9416 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6507 | 0.030 |
Why?
|
| Pneumonia | 1 | 2005 | 2142 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17598 | 0.030 |
Why?
|
| Histones | 1 | 2004 | 2570 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6224 | 0.030 |
Why?
|
| Hydroxyproline | 2 | 2002 | 110 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2003 | 14393 | 0.030 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2002 | 2047 | 0.030 |
Why?
|
| Humans | 10 | 2020 | 761098 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2012 | 103 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2012 | 89 | 0.020 |
Why?
|
| Bradykinin | 1 | 2012 | 205 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2012 | 427 | 0.020 |
Why?
|
| Macrophages | 1 | 2005 | 5754 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 753 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6482 | 0.020 |
Why?
|
| Captopril | 1 | 2010 | 262 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 878 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 2468 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 2815 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10083 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 3577 | 0.020 |
Why?
|
| Carbodiimides | 1 | 2005 | 9 | 0.020 |
Why?
|
| Heart Failure | 1 | 2010 | 11701 | 0.020 |
Why?
|
| Desiccation | 1 | 2005 | 78 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2005 | 174 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 193 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 1607 | 0.020 |
Why?
|
| Disease Progression | 1 | 2002 | 13506 | 0.010 |
Why?
|
| Porosity | 1 | 2005 | 348 | 0.010 |
Why?
|
| Mortality | 1 | 2016 | 2896 | 0.010 |
Why?
|
| Aorta | 1 | 2012 | 2040 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2010 | 2048 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 2002 | 150 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18217 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 1270 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5870 | 0.010 |
Why?
|
| Hyperoxia | 1 | 2003 | 258 | 0.010 |
Why?
|
| Tendons | 1 | 2005 | 558 | 0.010 |
Why?
|
| Quinazolinones | 1 | 2002 | 221 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 11066 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2019 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 1761 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3819 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29672 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80673 | 0.010 |
Why?
|
| Male | 6 | 2020 | 360675 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 1900 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2004 | 1172 | 0.010 |
Why?
|
| Integrins | 1 | 2003 | 834 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2005 | 1434 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 1831 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 1720 | 0.010 |
Why?
|
| Reaction Time | 1 | 2004 | 2087 | 0.010 |
Why?
|
| Echocardiography | 1 | 2010 | 5006 | 0.010 |
Why?
|
| Pulmonary Emphysema | 1 | 2003 | 683 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2002 | 1734 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 3266 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 169266 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4111 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2002 | 1331 | 0.010 |
Why?
|
| Collagen | 1 | 2002 | 2635 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 220835 | 0.010 |
Why?
|
| Piperidines | 1 | 2002 | 1656 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74219 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 41486 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13404 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5103 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58946 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9185 | 0.000 |
Why?
|
| United States | 1 | 2016 | 72337 | 0.000 |
Why?
|
| Female | 3 | 2016 | 392458 | 0.000 |
Why?
|
| Time Factors | 1 | 2005 | 39953 | 0.000 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_